Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al

Name: Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
Creator: Joséphine Dupuis
Published: 2023-12-18T07:43:28.686Z
Keywords: Descriptive Table

Dupuis, Joséphine

doi:10.17632/d23bwhdnkh.1

Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al

Published: 18 December 2023| Version 1 | DOI: 10.17632/d23bwhdnkh.1

Contributor:

Joséphine Dupuis

Description

Supplementary Table I: Adverse events during the follow-up period in patients treated with dupilumab.

Files

Institutions

Universite de Lille

Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al

Description

Files

Institutions

Categories

Licence